The “best” way to identify clinically significant, localized prostate cancer continues to evolve. But there is still no consensus about what that “best” way might be to do this, let alone any consensus about the detection of “clinically insignificant”, localized prostate cancer. … READ MORE …
Filed under: Diagnosis, Risk | Tagged: biopsy, Diagnosis, MRi-guided, risk, systematic | Leave a comment »
Cochrane reviews are structured, systematic, focused reviews of evidence in the field of medicine that either support or do not support specific forms of diagnosis and management of patients with or suspected of having particular disorders. … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk | Tagged: accuracy, biopsy, Diagnosis, fusion, MRI, MRi-guided, MRI/TRUS, prognosis, scan | 3 Comments »
Two newly published papers in the November issue of the Journal of Urology address prospective studies of the use of differing forms of MRI-guided biopsy in the diagnosis of prostate cancer. … READ MORE …
Filed under: Diagnosis, Risk | Tagged: accuracy, biopsy, MRi-guided, MRI/TRUS fusion, TRUS-guided | 5 Comments »
According to a media release issued yesterday by the City of Hope medical center in Los Angeles, they have become the first center in the USA to treat a patient with focused, MRI-guided, ultrasound technology using the InSightec system. … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk, Treatment | Tagged: focal, InSightec, localized, low risk, MRi-guided, Treatment, ultrasound | 3 Comments »
The London Health Sciences Center and the Lawson Clinical Research Institute in London, Ontario, Canada, have reported the first use of MRI-guided ultrasound ablation for the treatment of low-risk, prostate cancer. … READ MORE …
Filed under: Diagnosis, Management, Risk, Treatment | Tagged: ExAblate, focused, MRi-guided, ultrasound | 1 Comment »
According to an article published on the Medscape Oncology web site earlier today, two paper presented at the European Congress of Radiology have provided further evidence of the potential of MRI-guided biopsies in the diagnosis of prostate cancer. … READ MORE …
Filed under: Diagnosis, Risk | Tagged: biopsy, imaging, magnetic, MRi-guided, resonance | 4 Comments »
In October last year, the US Food and Drug Administration approved the ExAblate MRI-guided focused ultrasound technology for the treatment of pain associated with cancer metastasis to bones, which is obviously a potential benefit for men with late stage, metastatic prostate cancer. … READ MORE …
Filed under: Diagnosis, Management, Risk, Treatment | Tagged: ExAblate, focal, low risk, MRi-guided, Treatment, ultrasound | 24 Comments »
We often see recommendations that MRI-guided biopsies may be more accurate that transrectal ultrasound (TRUS)-guided biopsies in the diagnosis of prostate cancer. A new systematic review has attempted to assess the current status of data supporting or refuting this recommendation. … READ MORE …
Filed under: Diagnosis, Risk | Tagged: biopsy, comparison, MRi-guided, TRUS-guided | 11 Comments »
THE "NEW" PROSTATE CANCER INFOLINK 